Search research articles
Contact Us
Filters
Showing results (221-230 of 235) with videos related to
Page
of 24
Sort By:
The Lancet. Infectious Diseases
|
January 22, 2021
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
Jenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, et al.
Communications Medicine
|
March 16, 2023
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
Amy C Thomas, Elizabeth Oliver, Holly E Baum, et al.
Antibody Therapeutics
|
December 11, 2023
<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2
Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Eclinicalmedicine
|
August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
Guy de Bruyn, Joyce Wang, Annie Purvis, et al.
Lancet (London, England)
|
August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Jeremy P Carr, Jenny M MacLennan, Emma Plested, et al.
The Lancet. Respiratory Medicine
|
June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
The Journal of Infection
|
April 7, 2023
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
Robert H Shaw, Melanie Greenland, Arabella S V Stuart, et al.
Frontiers in Immunology
|
November 28, 2022
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2
Alice Halliday, Anna E Long, Holly E Baum, et al.
The New England Journal of Medicine
|
March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus disease
David W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 235) with videos related to
Sort By:
Page
of 24
The Lancet. Infectious Diseases
|
January 22, 2021
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
Jenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, et al.
Communications Medicine
|
March 16, 2023
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
Amy C Thomas, Elizabeth Oliver, Holly E Baum, et al.
Antibody Therapeutics
|
December 11, 2023
<i>In vitro</i> generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2
Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Eclinicalmedicine
|
August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
Guy de Bruyn, Joyce Wang, Annie Purvis, et al.
Lancet (London, England)
|
August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Jeremy P Carr, Jenny M MacLennan, Emma Plested, et al.
The Lancet. Respiratory Medicine
|
June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
The Journal of Infection
|
April 7, 2023
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
Robert H Shaw, Melanie Greenland, Arabella S V Stuart, et al.
Frontiers in Immunology
|
November 28, 2022
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2
Alice Halliday, Anna E Long, Holly E Baum, et al.
The New England Journal of Medicine
|
March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus disease
David W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Page
of 24